Press Release

The full press release can be downloaded as a pdf.

ChromaCon Enters an Agreement with AthenaES^® to Represent the Contichrom^® CUBE Chromatography Systems in the U.S.

Zurich (CH) and Baltimore (MD, USA), June 25, 2015. ChromaCon announced today that it has entered into a Distribution Agreement with AthenaES^® (Baltimore, MD) for the distribution, after-sales service and applications support of the Contichrom® CUBE Chromatography Systems. These instruments, which are manufactured in the U.S.A., combine a robust device with highly innovative software and applications capabilities that facilitate development of more productive biomolecular separations for process development and R&D purposes. The Contichrom^® CUBE Systems are unique in that they can be operated with batch and a number of novel cyclic and continuous processes, making them highly versatile tools for batch and continuous manufacturing. The Contichrom CUBE System was launched in January 2015 at the CHI PepTalk conference in San Diego, CA. GMP Scale-up systems operating ChromaCon’s novel twin-column processes are marketed worldwide by LEWA (Leonberg, Germany) and by LEWA Process Technologies (Devens, MA).

Michael Bavand, CEO of ChromaCon commented: "The United States, being the largest market for biopharmaceuticals, has been our focus for introducing the Contichrom^® CUBE Systems to the market. As continuous bio-manufacturing is gaining traction, we help to intensify manufacturing and to dramatically reduce costs. The Contichrom^® CUBE Systems are the only chromatographic instruments in the marketplace offering multicolumn processes for capture and polish applications. We have been working with AthenaES for some time and are convinced that they are excellent partners combining chromatographic equipment and process know-how with marketing strength.”

About AthenaES

AthenaES^® was founded in 1994 and specializes in the development and commercialization of advanced biotechnology-based products. The company markets its products and services through two business units. The Athena Enzymes Systems Group™ provides specialty reagents, proteins and instruments for the production and recovery of recombinant proteins. The portfolio of 300+ products is used throughout the world by researchers and commercial producers. The company’s product portfolio includes: expression systems for production of proteins in E. coli; culture media designed to increase the expression of recombinant proteins; protein refolding and recovery reagents; specialty proteins for research, environmental and specialty chemical applications; cell culture reagents and serum-free medium for the propagation of human cell lines; and chromatography instruments, resins and accessories. For more information please visit www.athenaes.com.

About ChromaCon

ChromaCon AG is a private Life Science Tool company located in Zürich, Switzerland, providing novel, best-in-class chromatographic process solutions to the biopharmaceutical industry. ChromaCon has developed and patented process principles, process control, equipment designs and operating software for cyclic and continuous chromatography, providing significant CAPEX and OPEX cost savings and enabling scalable chromatographic solutions for large scale purification applications. Its Contichrom^® CUBE equipment line is marketed worldwide by ChromaCon and its distributors and its HPLC lab-scale equipment is co-marketed worldwide with its partner Knauer (Germany). ChromaCon has provided global licenses for its process technologies to LEWA for implementation into GMP scale-up systems. In addition, ChromaCon develops and markets affinity purification solutions for column and membrane chromatography applications and tools for site-specific protein conjugation.

ChromaCon Contact

Dr. Michael Bavand, CEO, michael.bavand@chromacon.com